EnzymeRx's Other Investors

EnzymeRx raised a round of funding on , . Investors include Pequot Capital Mangement.

EnzymeRx is a private, clinical stage biotechnology company developing uricase-PEG 20 for the treatment of resistant and refractory gout and related indications in which hyperuricemia plays a causativ…

Articles about EnzymeRx's Other Investors: